These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 36768235)

  • 1. Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer's Disease Progression.
    Andronie-Cioara FL; Ardelean AI; Nistor-Cseppento CD; Jurcau A; Jurcau MC; Pascalau N; Marcu F
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics.
    Thakur S; Dhapola R; Sarma P; Medhi B; Reddy DH
    Inflammation; 2023 Feb; 46(1):1-17. PubMed ID: 35986874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroinflammation Biomarkers in the AT(N) Framework Across the Alzheimer's Disease Continuum.
    Bieger A; Rocha A; Bellaver B; Machado L; Da Ros L; Borelli WV; Therriault J; Macedo AC; Pascoal TA; Gauthier S; Rosa-Neto P; Zimmer ER
    J Prev Alzheimers Dis; 2023; 10(3):401-417. PubMed ID: 37357281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting the intersection of microglial activation and neuroinflammation in Alzheimer's disease from the perspective of ferroptosis.
    Wang M; Tang G; Zhou C; Guo H; Hu Z; Hu Q; Li G
    Chem Biol Interact; 2023 Apr; 375():110387. PubMed ID: 36758888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of neuroinflammation in Alzheimer's disease via nanoparticle-loaded phytocompounds with anti-inflammatory and autophagy-inducing properties.
    Nayak V; Patra S; Rout S; Jena AB; Sharma R; Pattanaik KP; Singh J; Pandey SS; Singh RP; Majhi S; Singh KR; Kerry RG
    Phytomedicine; 2024 Jan; 122():155150. PubMed ID: 37944239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease.
    Hampel H; Caraci F; Cuello AC; Caruso G; Nisticò R; Corbo M; Baldacci F; Toschi N; Garaci F; Chiesa PA; Verdooner SR; Akman-Anderson L; Hernández F; Ávila J; Emanuele E; Valenzuela PL; Lucía A; Watling M; Imbimbo BP; Vergallo A; Lista S
    Front Immunol; 2020; 11():456. PubMed ID: 32296418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation: A Major Target for Compounds to Control Alzheimer's Disease.
    Maccioni RB; Navarrete LP; González A; González-Canacer A; Guzmán-Martínez L; Cortés N
    J Alzheimers Dis; 2020; 76(4):1199-1213. PubMed ID: 32597798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of trigger receptor 2 expressed on myeloid cells in neuroinflammation－neglected multidimensional regulation of microglia.
    Zhang X; Chen X; Zhang L; Sun Y; Liang Y; Li H; Zhang Y
    Neurochem Int; 2023 Dec; 171():105639. PubMed ID: 37926352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
    Cai Z; Hussain MD; Yan LJ
    Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroinflammation in Alzheimer's Disease: Microglia, Molecular Participants and Therapeutic Choices.
    Wang H; Shen Y; Chuang H; Chiu C; Ye Y; Zhao L
    Curr Alzheimer Res; 2019; 16(7):659-674. PubMed ID: 31580243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease.
    Thawkar BS; Kaur G
    J Neuroimmunol; 2019 Jan; 326():62-74. PubMed ID: 30502599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroinflammation, its Role in Alzheimer's Disease and Therapeutic Strategie.
    Kiraly M; Foss JF; Giordano T
    J Prev Alzheimers Dis; 2023; 10(4):686-698. PubMed ID: 37874089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer's Disease.
    Tamburini B; Badami GD; La Manna MP; Shekarkar Azgomi M; Caccamo N; Dieli F
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of TREM2 in Alzheimer's Disease: A Long Road Ahead.
    Kulkarni B; Kumar D; Cruz-Martins N; Sellamuthu S
    Mol Neurobiol; 2021 Oct; 58(10):5239-5252. PubMed ID: 34275100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes: A missing link between chronic systemic inflammation and Alzheimer's disease?
    Ozansoy M; Mikati H; Velioglu HA; Yulug B
    Biomed Pharmacother; 2023 Mar; 159():114161. PubMed ID: 36641928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein
    Jiang M; Zhang X; Yan X; Mizutani S; Kashiwazaki H; Ni J; Wu Z
    Brain Behav Immun; 2021 Nov; 98():1-12. PubMed ID: 34391814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p38 Inhibition Decreases Tau Toxicity in Microglia and Improves Their Phagocytic Function.
    Perea JR; Bolós M; Cuadros R; García E; García-Escudero V; Hernández F; McManus RM; Heneka MT; Avila J
    Mol Neurobiol; 2022 Mar; 59(3):1632-1648. PubMed ID: 35006531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model.
    Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A
    Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.